Lesley Taylor

Anti-CD3 Monoclonal Antibody in New-Onset Type 1 Diabetes Mellitus

Kevan C. Herold, William Hagopian, Julie Auger et al. · New England Journal of Medicine · 2002 · 1.2K citations · Full text

A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects

Lesley Taylor, Barry E. Gidal, Graham Blakey et al. · CNS Drugs · 2018 · 448 citations · Full text

A Phase 1, Open‐Label, Parallel‐Group, Single‐Dose Trial of the Pharmacokinetics and Safety of Cannabidiol (CBD) in Subjects With Mild to Severe Hepatic Impairment

Lesley Taylor, Julie C. Crockett, Bola Tayo et al. · The Journal of Clinical Pharmacology · 2019 · 98 citations · Full text

Severe Hepatic Impairment, Pharmacotherapy, Cannabinoid Pharmacology +20

α-1-Antitrypsin Deficiency in Liver Disease: The Extent of the Problem

Rosemarie Lucianin Fisher, Lesley Taylor, Sheila Sherlock · Gastroenterology · 1976 · 72 citations · Full text

Hepatology, Autoimmune Disease, Liver Physiology +10

A Phase I, Open-Label, Parallel-Group, Single-Dose Trial of the Pharmacokinetics, Safety, and Tolerability of Cannabidiol in Subjects with Mild to Severe Renal Impairment

Bola Tayo, Lesley Taylor, Farhad Sahebkar et al. · Clinical Pharmacokinetics · 2019 · 62 citations · Full text